PEGylating a bacteriophage endolysin inhibits its bactericidal activity

AMB Express

Volumn 1, Issue 1, 2011, Pages 1-5

  Resch, Gregory ^a,b   Moreillon, Philippe ^b   Fischetti, Vincent A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Bacteriophage; Cpl 1; Endolysin; Enzybiotic; PEGylation; S. pneumoniae

Indexed keywords

BACTERIAL TOXIN; CPL 1; ENDOLYSIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; CPL 1 GENE; DNA SEQUENCE; ENZYME ACTIVITY; GENE; GENE MUTATION; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STREPTOCOCCUS PNEUMONIAE;

EID: 84863507788     PISSN: None     EISSN: 21910855     Source Type: Journal    
DOI: 10.1186/2191-0855-1-29     Document Type: Article

References (17)

1. Abramoff MD, Magalhaes PJ, Ram SJ (2004) Image Processing with Image J. Biophotonic Int 11:36-42
2. Diaz E, Lopez R, Garcia JL (1990) Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. Proc Natl Acad Sci USA 87:8125-8129. doi:10.1073/pnas.87.20.8125
3. Entenza JM, Loeffler JM, Grandgirard D, Fischetti VA, Moreillon P (2005) Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 49:4789-4792. doi:10.1128/AAC.49.11.4789-4792.2005
4. Fuller JD, Low DE (2005) A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 41:118-121. doi:10.1086/430829
5. Gaberc-Porekar V, Zore I, Podobnik B, Menart V (2008) Obstacles and pitfalls in the PEGylation of therapeutic proteins. Curr Opin Drug Discov Devel 11:242-250
6. Grandgirard D, Loeffler JM, Fischetti VA, Leib SL (2008) Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J Infect Dis 197:1519-1522. doi:10.1086/587942
7. Jacobs MR (2004) Streptococcus pneumoniae: epidemiology and patterns of resistance. The American journal of medicine 117(Suppl 3A):3S-15S
8. Klugman KP (2002) Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections. Eur Respir J, Suppl 36: 3s-8s
9. Loeffler JM, Djurkovic S, Fischetti VA (2003) Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 71:6199-6204. doi:10.1128/IAI.71.11.6199-6204.2003
10. Loeffler JM, Fischetti VA (2003) Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother 47:375-377. doi:10.1128/AAC.47.1.375-377.2003
11. Loeffler JM, Nelson D, Fischetti VA (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294:2170-2172. doi:10.1126/science.1066869
12. Perez-Dorado I, Campillo NE, Monterroso B, Hesek D, Lee M, Paez JA, Garcia P, Martinez-Ripoll M, Garcia JL, Mobashery S, Menendez M, Hermoso JA (2007) Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1. J Biol Chem 282:24990-24999. doi:10.1074/jbc.M704317200
13. Ramon J, Saez V, Baez R, Aldana R, Hardy E (2005) PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative. Pharm Res 22:1374-1386
14. Resch G, Moreillon P, Fischetti VA (2011) A Stable Phage Lysin (Cpl-1) Dimer with Increased Anti-Pneumococcal Activity and Decreased Plasma Clearance. Int Journal of Antimicrobial Agents (in press)
15. Romero P, Lopez R, Garcia E (2007) Key role of amino acid residues in the dimerization and catalytic activation of the autolysin LytA, an important virulence factor in Streptococcus pneumoniae. J Biol Chem 282:17729-17737. doi:10.1074/jbc.M611795200
16. Veronese FM, Pasut G (2005) PEGylation, successful approach to drug delivery. Drug Discov Today 10:1451-1458. doi:10.1016/S1359-6446(05)03575-0
17. Walsh S, Shah A, Mond J (2003) Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob Agents Chemother 47:554-558. doi:10.1128/AAC.47.2.554- 558.2003.